Home
News
In Focus
Business
Metro
Nation
World
Sports
Feature
Opinion
View more »Opinion Columns
Wan LixinOpinion deputy editor of Shanghai Daily
Restaurants get off to a quick start thanks to game-changing policies
High service charges on event ticket refunds call for further regulation
Sunday
- Subscribe
Related News
Researchers make nanoparticle find on lung damage
By Tan Ee Lyn |
June 14, 2009, Sunday
|
Print Edition
Print Edition
CHINESE researchers appear to have uncovered how nanoparticles may cause lung damage when used in medicine for diagnosis and delivering drugs.
Nanotechnology, or the science of the extremely tiny, is an important industry. One nanometer is one-billionth of a meter.
Apart from medicine, it is used in products like sporting goods, cosmetics and electronics and has a projected annual market of about US$1 trillion by 2015.
However, concerns are growing that it may have toxic effects, particularly to the lungs.
In an article in the Journal of Molecular Cell Biology, the Chinese experts said a class of nanoparticles used in medicine, ployamidoamine dendrimers (PAMAMs), may cause lung damage by triggering a type of programmed cell death known as autophagic cell death.
In experiments, they observed how several types of PAMAMs killed human lung cells but found no evidence that the cells were dying by apoptosis, a natural and common type of cell death.
In a subsequent experiment in mice, they injected an autophagy inhibitor in mice and later exposed the rodents to nanoparticles and found that it "significantly ameliorated the lung damage and improved survival rates."
"This provides us with a promising lead for developing strategies to prevent lung damage caused by nanoparticles," said the leader of the team, Jiang Chengyu, a molecular biologist at the Chinese Academy of Medical Sciences in Beijing.
Scientists hope nanoparticles will eventually be able to improve the effectiveness of drugs and gene therapy by carrying them to the right place in the body and by targeting specific tissues and regulating the release of drugs.
Nanotechnology, or the science of the extremely tiny, is an important industry. One nanometer is one-billionth of a meter.
Apart from medicine, it is used in products like sporting goods, cosmetics and electronics and has a projected annual market of about US$1 trillion by 2015.
However, concerns are growing that it may have toxic effects, particularly to the lungs.
In an article in the Journal of Molecular Cell Biology, the Chinese experts said a class of nanoparticles used in medicine, ployamidoamine dendrimers (PAMAMs), may cause lung damage by triggering a type of programmed cell death known as autophagic cell death.
In experiments, they observed how several types of PAMAMs killed human lung cells but found no evidence that the cells were dying by apoptosis, a natural and common type of cell death.
In a subsequent experiment in mice, they injected an autophagy inhibitor in mice and later exposed the rodents to nanoparticles and found that it "significantly ameliorated the lung damage and improved survival rates."
"This provides us with a promising lead for developing strategies to prevent lung damage caused by nanoparticles," said the leader of the team, Jiang Chengyu, a molecular biologist at the Chinese Academy of Medical Sciences in Beijing.
Scientists hope nanoparticles will eventually be able to improve the effectiveness of drugs and gene therapy by carrying them to the right place in the body and by targeting specific tissues and regulating the release of drugs.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
